$Recro Pharma, Inc.(REPH)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-01 AccNo: 0000215457-18-004538 Size: 12 KB 网页链接
$Recro Pharma, Inc.(REPH)$ 内部交易: 2018-01-04,10% Owner,SCP Vitalife Partners II LP ,卖出,4732普通股, $8.84
$Recro Pharma, Inc.(REPH)$ 内部交易: 2018-01-04,10% Owner,SCP Vitalife Partners (Israel) ,卖出,1579普通股, $8.84
$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2018-01-08 AccNo: 0001193125-18-005087 Size: 20 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2018-01-08 AccNo: 0001193125-18-004695 Size: 18 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Recro Pharma, Inc.(REPH)$ 内部交易: 2018-01-03,10% Owner,SCP Vitalife Partners (Israel) ,卖出,6635普通股, $8.73
$Recro Pharma, Inc.(REPH)$ 内部交易: 2018-01-02,10% Owner,SCP Vitalife Partners (Israel) ,卖出,6329普通股, $9.04
$Recro Pharma, Inc.(REPH)$ 内部交易: 2018-01-03,10% Owner,SCP Vitalife Partners II LP ,卖出,19863普通股, $8.73
$Recro Pharma, Inc.(REPH)$ 内部交易: 2018-01-02,10% Owner,SCP Vitalife Partners II LP ,卖出,18947普通股, $9.04
$Recro Pharma, Inc.(REPH)$ 内部交易: 2018-12-29,10% Owner,SCP Vitalife Partners II LP ,卖出,12305普通股, $9.19